APA (7th ed.) Citation

Jingyue Qiu, Jiakuo Liu, Kexin Cai, Ting Xu, Wenwen Liu, Fei Lin, . . . Ning Shi. (2024). Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: A systematic review and meta-analysis of randomized controlled trials. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jingyue Qiu, Jiakuo Liu, Kexin Cai, Ting Xu, Wenwen Liu, Fei Lin, Fei Lin, and Ning Shi. Efficacy and Safety of the S1PR Modulator Etrasimod in the Treatment of Moderately to Severely Active Ulcerative Colitis During the Induction Phase: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Jingyue Qiu, et al. Efficacy and Safety of the S1PR Modulator Etrasimod in the Treatment of Moderately to Severely Active Ulcerative Colitis During the Induction Phase: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Frontiers Media S.A., 2024.